Diabetes is a global epidemic and the number of people with diabetes globally is growing at an alarming rate. An estimated 463 million adults (20-79 years), or about 1 in 11 adults worldwide, are living with diabetes across the world in 2019; by 2045 this will rise to 700 million1. Globally, the number of people … Continue reading Early Insulinization Can be Key to Effective Diabetes Management
Diabetes Mellitus is a major health issue with nearly half a billion people living with this ailment globally. Diabetes is a serious, chronic or long-term condition that occurs when there are elevated levels of glucose in a person’s blood because their body cannot produce any or enough of the hormone insulin, or cannot effectively use … Continue reading A Disease of Halves: Why better patient adherence to treatment is important to manage diabetes?
Professor Vivekanand Jha shares his views on how Dialysis is one of the first technological innovations in medicine and why we need to leverage this technology to address the huge kidney failure burden our country faces.
A Disease may be Rare but Hope should not be!
Mr. Suresh Subramanian, Senior Vice President & Head Branded Formulations, Biocon shares his views on how KRABEVA® can make a significant impact in the biosimilars space.